Literature DB >> 16404525

Efficient library synthesis of imidazoles using a multicomponent reaction and microwave irradiation.

E Gelens1, F J J De Kanter, R F Schmitz, L A J M Sliedregt, B J Van Steen, Chris G Kruse, R Leurs, M B Groen, R V A Orru.   

Abstract

Optimization of Radziszewski's four-component reaction employing a microwave-assisted protocol, led to a small library of 48 imidazoles with a success rate of 65% (conversion > 45%). All three diversity points of the four-component reaction were varied. Aromatic and aliphatic inputs were successfully implemented and mono-, di-, tri- and tetrasubstituted imidazoles with various substitution patterns were synthesized. Furthermore, unsymmetrical diketones could successfully be used which improved the intrinsic diversity of the method significantly. If the unsymmetrical diketone 1,2-phenylpropanedione (R1 and R2) was used two regioisomers were formed. Depending on the type of amine (R4) and aldehyde (R3) applied, regioselectivity was modest to good. Based on these results, a reaction mechanism is proposed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16404525     DOI: 10.1007/s11030-006-8695-3

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  8 in total

Review 1.  Increasing rates of reaction: microwave-assisted organic synthesis for combinatorial chemistry.

Authors:  Amy Lew; Peter O Krutzik; Matthew E Hart; A Richard Chamberlin
Journal:  J Comb Chem       Date:  2002 Mar-Apr

2.  Imidazole-containing diarylether and diarylsulfone inhibitors of farnesyl-protein transferase.

Authors:  C J Dinsmore; T M Williams; T J O'Neill; D Liu; E Rands; J C Culberson; R B Lobell; K S Koblan; N E Kohl; J B Gibbs; A I Oliff; S L Graham; G D Hartman
Journal:  Bioorg Med Chem Lett       Date:  1999-12-06       Impact factor: 2.823

3.  1,2-Diarylimidazoles as potent, cyclooxygenase-2 selective, and orally active antiinflammatory agents.

Authors:  I K Khanna; R M Weier; Y Yu; X D Xu; F J Koszyk; P W Collins; C M Koboldt; A W Veenhuizen; W E Perkins; J J Casler; J L Masferrer; Y Y Zhang; S A Gregory; K Seibert; P C Isakson
Journal:  J Med Chem       Date:  1997-05-23       Impact factor: 7.446

4.  Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity.

Authors:  J L Adams; J C Boehm; T F Gallagher; S Kassis; E F Webb; R Hall; M Sorenson; R Garigipati; D E Griswold; J C Lee
Journal:  Bioorg Med Chem Lett       Date:  2001-11-05       Impact factor: 2.823

5.  Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase.

Authors:  N J Liverton; J W Butcher; C F Claiborne; D A Claremon; B E Libby; K T Nguyen; S M Pitzenberger; H G Selnick; G R Smith; A Tebben; J P Vacca; S L Varga; L Agarwal; K Dancheck; A J Forsyth; D S Fletcher; B Frantz; W A Hanlon; C F Harper; S J Hofsess; M Kostura; J Lin; S Luell; E A O'Neill; S J O'Keefe
Journal:  J Med Chem       Date:  1999-06-17       Impact factor: 7.446

6.  Design, synthesis, and structure--activity relationship studies for a new imidazole series of J774 macrophage specific acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors.

Authors:  T P Maduskuie; R G Wilde; J T Billheimer; D A Cromley; S Germain; P J Gillies; C A Higley; A L Johnson; P Pennev; E J Shimshick
Journal:  J Med Chem       Date:  1995-03-31       Impact factor: 7.446

7.  Efficient synthesis of imidazoles from aldehydes and 1,2-diketones using microwave irradiation.

Authors:  Scott E Wolkenberg; David D Wisnoski; William H Leister; Yi Wang; Zhijian Zhao; Craig W Lindsley
Journal:  Org Lett       Date:  2004-04-29       Impact factor: 6.005

8.  Identification of 4-(1H-imidazol-4(5)-ylmethyl)pyridine (immethridine) as a novel, potent, and highly selective histamine H(3) receptor agonist.

Authors:  Ruengwit Kitbunnadaj; Obbe P Zuiderveld; Bernard Christophe; Saskia Hulscher; Wiro M P B Menge; Edith Gelens; Erwin Snip; Remko A Bakker; Sylvain Celanire; Michel Gillard; Patrice Talaga; Henk Timmerman; Rob Leurs
Journal:  J Med Chem       Date:  2004-05-06       Impact factor: 7.446

  8 in total
  7 in total

1.  Cyclometalated Ruthenium(II) Complexes Derived from α-Oligothiophenes as Highly Selective Cytotoxic or Photocytotoxic Agents.

Authors:  Goutam Ghosh; Katsuya L Colón; Anderson Fuller; Tariq Sainuddin; Evan Bradner; Julia McCain; Susan M A Monro; Huimin Yin; Marc W Hetu; Colin G Cameron; Sherri A McFarland
Journal:  Inorg Chem       Date:  2018-06-21       Impact factor: 5.165

2.  New multicomponent approach for the synthesis of benzo[c]coumarin derivatives over MgO under solvent-free conditions.

Authors:  Hassan Valizadeh; Ashraf Fakhari
Journal:  Mol Divers       Date:  2010-07-22       Impact factor: 2.943

3.  One-Pot Synthesis of Imidazole-4-Carboxylates by Microwave-Assisted 1,5-Electrocyclization of Azavinyl Azomethine Ylides.

Authors:  Lisa Preti; Orazio A Attanasi; Emilia Caselli; Gianfranco Favi; Claudia Ori; Paolo Davoli; Fulvia Felluga; Fabio Prati
Journal:  European J Org Chem       Date:  2010-08

Review 4.  Microwave multicomponent synthesis.

Authors:  Helmut M Hügel
Journal:  Molecules       Date:  2009-12-01       Impact factor: 4.411

5.  Influence of Steric Effect on the Pseudo-Multicomponent Synthesis of N-Aroylmethyl-4-Arylimidazoles.

Authors:  Nerith Rocio Elejalde-Cadena; Mayra García-Olave; David Figueroa; Pietro Vidossich; Gian Pietro Miscione; Jaime Portilla
Journal:  Molecules       Date:  2022-02-09       Impact factor: 4.411

6.  TMSOTf-catalyzed synthesis of trisubstituted imidazoles using hexamethyldisilazane as a nitrogen source under neat and microwave irradiation conditions.

Authors:  Kesatebrhan Haile Asressu; Chieh-Kai Chan; Cheng-Chung Wang
Journal:  RSC Adv       Date:  2021-08-19       Impact factor: 4.036

7.  One-pot synthesis of symmetric imidazolium ionic liquids N,N-disubstituted with long alkyl chains.

Authors:  Giacomo Damilano; Demian Kalebić; Koen Binnemans; Wim Dehaen
Journal:  RSC Adv       Date:  2020-06-03       Impact factor: 3.361

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.